J&J Takes Innovative, If Pricey, Route To Ending Hip Suits
In Tuesday's hip implant deal, Johnson & Johnson took the unusual step of accepting responsibility for most of the plaintiffs' insurance liens for surgery costs, a promise that jacks up —...To view the full article, register now.
Already a subscriber? Click here to view full article